Get startedLog in
    Picture of Pacira Biosciences logo

    PCRX — Pacira Biosciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapSuper Stock
    All News

    Brief: Pacira Biosciences' Pcrx-201 Granted Regenerative Medicine Advance Therapy (Rmat) Designation For The Treatment Of Osteoarthritis Of The Knee

    Picture of Pacira Biosciences logoPacira Biosciences
    13/03/2024 12:36
    March 13 (Reuters) - Pacira Biosciences Inc  PCRX.O :
    * PACIRA BIOSCIENCES ANNOUNCES PCRX-201 GRANTED REGENERATIVE
MEDICINE ADVANCE THERAPY (RMAT) DESIGNATION FOR THE TREATMENT OF
OSTEOARTHRITIS OF THE KNEE

Source text for Eikon:  ID:nGNXc5WsrT 
Further company coverage:  PCRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Pacira Biosciences

    See all news